Completed An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects NCT03082937 Conditions Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +20 more Locations Quotient Clinical — Ruddington, Nottingham, United Kingdom View Trial Details
Completed A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384 NCT02963077 Conditions Abnormalities, Multiple, Alagille Syndrome, Bile Duct Diseases, +20 more Locations Not specified View Trial Details
